Publication | Closed Access

Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia

Metabolic SyndromeLipid DisorderCardiovascular DiseasePharmacogenetic PredictorsMedicineGenetic EpidemiologyHyperlipidemiaLipid-lowering ResponseDyslipidemiaLipoprotein MetabolismPublic HealthPharmacologyAtherosclerosisEpidemiologyChilean Subjects